A personalised vaccine against melanoma can more than double the survival
rate for patients with the advanced form of this skin cancer. Doctors at
Jefferson Medical College in Philadelphia create customised vaccines from
patients’ own cancer cells by inactivating them and altering their surface
proteins with dinitrophenol. Five-year survival rates in 214 patients with
advanced disease increased from around 20 per cent to 50 per cent and a
randomised phase III trial of 400 patients across the US is planned.
To continue reading, today with our introductory offers
Advertisement
More from 91av
Explore the latest news, articles and features
Popular articles
Trending 91av articles
1
Red-light therapy does have health benefits but not the ones you think
2
PCOS postpones perimenopause and allows pregnancies at older ages
3
Man destined for Alzheimer's may have been saved by accidental therapy
4
A lost ancient script reveals how writing as we know it really began
5
Prebiotic chewing gum could be helpful for gum disease
6
Hantavirus outbreak will not cause a covid-style pandemic, says WHO
7
Coffee's mood-boosting effects aren't just down to caffeine
8
The greatest David Attenborough documentaries you really need to watch
9
300-year-old experiment could become world's best dark matter detector
10
Woman in cancer remission without treatment in highly unusual case
